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Insulin homeostasis in pancreatic b cells is now
recognized as a critical element in the progression
of obesity and type II diabetes (T2D). Proteins that
interact with insulin to direct its sequential synthe-
sis, folding, trafficking, and packaging into reserve
granules in order to manage release in response
to elevated glucose remain largely unknown. Using
a conformation-based approach combined with
mass spectrometry, we have generated the insulin
biosynthetic interaction network (insulin BIN), a pro-
teomic roadmap in the b cell that describes the
sequential interacting partners of insulin along the
secretory axis. The insulin BIN revealed an abundant
C2 domain-containing transmembrane protein 24
(TMEM24) that manages glucose-stimulated insulin
secretion from a reserve pool of granules, a critical
event impaired inpatientswith T2D. The identification
of TMEM24 in the context of a comprehensive
set of sequential insulin-binding partners provides
a molecular description of the insulin secretory
pathway in b cells.
INTRODUCTION
Given the impact of a high-fat, high-sugar diet leading to obesity,
metabolic syndrome, and type II diabetes (T2D) (Ashcroft and
Rorsman, 2012), it is crucial to understand the protein interac-
tions that govern the biogenesis and release of insulin into
plasma. Orci and colleagues initially described the trafficking
itinerary of insulin through the secretory pathway of the pancre-Celatic b cell using electron microscopy (Orci et al., 1985, 1986).
Mature insulin is synthesized in the endoplasmic reticulum
(ER), transported through the secretory pathway, and then
stored in two functionally distinct pools of granules: the reserve
pool (RP) and the readily releasable pool (RRP), from which insu-
lin is released in a biphasic fashion upon stimulation with glucose
(Seino et al., 2011). We now know that folding in the ER, ER-to-
Golgi transport, and secretion of proteins to the extracellular
milieu in response to stimulus is aided andmonitored by the pro-
teostasis network that makes continual adjustments to the pro-
tein fold (Balch et al., 2008; Hutt and Balch, 2013; Powers and
Balch, 2013). In human disease, early components of the folding
machinery play a critical role in b cell biology (Back andKaufman,
2012). Surprisingly, little is known about the proteins that interact
with insulin directly or indirectly to promote conformational
maturation required to maintain the biphasic insulin release
that is defective in T2D.
To explore the proteins promoting insulin synthesis and
folding, granule maturation, and secretion, previous proteomics
studies focused on whole human pancreatic islets under basal
(Waanders et al., 2009) and elevated glucose levels (Schrimpe-
Rutledge et al., 2012). Usingmass spectrometry of purified intact
islets (which contain multiple cell types), these studies identified
a large number ofmetabolic and signaling pathway components.
Studies using insulin granules purified from a rat insulinoma cell
line, INS1-E, by subcellular fractionation with or without immu-
noaffinity purification of the granule surface-associated protein
VAMP-2 (Brunner et al., 2007; Hickey et al., 2009) identified a
smaller subset of proteins enriched in granules, as well as lyso-
somal and mitochondrial proteins likely due to cosedimentation
of these organelles during fractionation (Suckale and Solimena,
2010). Secretory granule membranes purified from mouse insu-
linomaMIN6 cells showed that p23, a p24 family protein involved
in vesicular transport, was localized to the insulin secretoryl Reports 4, 921–930, September 12, 2013 ª2013 The Authors 921
Figure 1. Insulin BIN
(A) Schematic for insulin maturation pathway in pancreatic b cell.
(B) Human orthologs of secretory proteins are identified and insulin:proinsulin binding ratios are calculated and plotted on a logarithmic (base 2) scale. In the inset,
silver stain of eluate fromMIN6 cells immunoprecipitatedwith control IgG (lane 1) or Protein G beads alone (lane 2) or with antibodies to proinsulin (lane 3) or insulin
(lane 4) is shown.
(C) Proteins that belong to the secretory compartment of insulin BIN are denoted as nodes (ovals; hexagons were used for proteins previously identified in
proteomic studies of insulin secretory granules from INS1-E cells [Brunner et al., 2007; Hickey et al., 2009]). Proteins are arranged according to their location in the
secretory pathway. Color of the node represent more binding to insulin (green), proinsulin (red), or to both (gray), based on log2 values of insulin to proinsulin
(legend continued on next page)
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granule membrane (Hosaka et al., 2007). Although these data
provide a glimpse of the proteomic composition of islet cell types
and the insulin secretory granule, they do not identify the pro-
teins that interact directly or indirectly with insulin to manage
its synthesis, folding, trafficking, and packaging for storage in
granules—the central axis dictating b cell function.
Herein, we report an insulin biosynthetic interaction network
(insulin BIN) that describes in molecular terms the secretory
pathway of the islet b cell. Using a conformation-based
approach coupled to mass spectrometry, we characterized pro-
tein interactions for the immature insulin separately from interac-
tions found with the mature insulin. To address the importance
of highly abundant proteins recovered in the insulin BIN in
b cell biology, we characterized one prominent insulin BIN pro-
tein, transmembrane protein 24 (TMEM24; also referred to as
C2 domain-containing protein 2-like or C2CD2L). Molecular
analysis of TMEM24 identifies it as a pancreatic islet-enriched
protein that plays a key role in regulating glucose-sensitive
insulin release from the reserve pool of granules. Our results
provide a database that can now be used to dissect the
biochemical and molecular mechanisms responsible for b cell
secretory pathway function in insulin biogenesis and release.
RESULTS
Defining the Insulin BIN
During granule maturation, the conformational precursor of insu-
lin (proinsulin) generated by cotranslational insertion into the ER
is transported to the Golgi, where it is proteolytically cleaved
to yield the mature insulin (Furuta et al., 1998; Zhu et al., 2002).
Insulin is then stored in two pools of secretory granules, leading
to biphasic, glucose-stimulated insulin secretion (GSIS) (Fig-
ure 1A). The vast majority of granules belong to the slow-
releasing RP responsible for the sustained second phase of
GSIS, whereas a small fraction (5%) exist in the RRP, mediating
the first phase of GSIS (Ohara-Imaizumi et al., 2002; Wang and
Thurmond, 2009).
To define the sequential interacting partners that bind to insu-
lin during its maturation from the ER to storage granules, we
immunopurified proinsulin alone and proinsulin/insulin-contain-
ing protein complexes frommouse insulinomaMIN6 cells, a vali-
dated model of insulin maturation and secretion. We used two
monoclonal antibodies that differentiate between the maturation
states of insulin during its transit from the ER to post-Golgi
granules. The first conformation-specific antibody binds to the
C-peptide region present only in mouse proinsulin and not in
mature insulin (Figure S1A), whereas the second antibody binds
to a common epitope present in both proinsulin and mature
insulin (Figure 1B, inset). Proteins that differentially bound to pro-
insulin and insulin were identified by comparing the two protein
complexes using mass spectrometry. High-confidence proteinsbinding ratios and statistical confidence (proteins with pR 0.5 for differential bind
the edges in the network that show direct or indirect interaction with insulin identi
the interactome based on PINA, and blue lines connect insulin to proteins that ha
association with diabetic conditions.
(D) Heatmap of 50 proteins with highest fractional spectral coverage in insulin an
See also Figures S1 and S2 and Tables S1, S2, and S3.
Celwere then organized by International Protein Index (IPI) acces-
sion number and subcellular compartment as reported by the
Gene Ontology (GO) (Ashburner et al., 2000), followed bymanual
curation based on known protein-protein interactions and pub-
lished literature. Final lists of proteins associated with the secre-
tory pathway are listed in Tables S1 and S2.
Using normalized spectral counts assigned to statistically sig-
nificant protein-protein interactions, insulin:proinsulin binding
ratios were computed and plotted on a logarithmic (base 2) scale
to highlight preferential binding partners to either proinsulin,
insulin, or both (Figure 1B; Table S3). The insulin BIN contains
proteins from multiple subcellular compartments, whose func-
tions include protein synthesis, folding, trafficking, and secre-
tion. We used the comprehensive list of identified secretory
pathway proteins (Table S3) in order to validate known features
and to elucidate additional players involved in insulin maturation
and secretion. Including insulin, we found 230 insulin BIN
proteins to be annotated by GO and/or previously published
literature as localized to secretory compartments and reflect
interactions that could occur within the lumen of secretory com-
partments or through transmembrane proteins that link cargo
proteins in the lumen to cytosolic structural components facili-
tating insulin synthesis, folding, trafficking, and secretion. We
further compared our data set with two recent human islet prote-
omic (Schrimpe-Rutledge et al., 2012; Waanders et al., 2009)
and gene expression analyses (Mahdi et al., 2012; Marselli
et al., 2010). Of the 230 proteins, we had an overlap of 83%
and 100% with the islet proteome and gene expression arrays,
respectively, validating the relevance of our data set in human
islets (Table S3; Figure S1B; see Discussion). Based on the insu-
lin:proinsulin binding ratios (Figure 1B), proteins in insulin BIN
could be divided into three broad groups. Group 1 had log2 ratios
smaller than2.0, indicating at least 4-fold (22.0) stronger inter-
action with proinsulin over insulin. This ratio would suggest roles
for these proteins in ER to early Golgi function. Group 2 had
ratios between 2.0 and 2.0, suggesting their potential to
interact with both proinsulin and insulin, and therefore likely to
include intermediate steps in maturation through later Golgi
steps. Group 3 proteins had log2 ratios greater than 2.0, indi-
cating at least a 4-fold preferential binding to insulin over proin-
sulin and therefore potentially components that are found and
function in late secretory pathway/granule maturation. Differen-
tial interaction of select proteins in each group with proinsulin
and/or insulin was further validated by western blotting of inde-
pendent experimental replicates (Figure S1C).
Arranging all 230 secretory proteins in the insulin BIN accord-
ing to their likely subcellular localization suggests that proinsulin-
binding proteins (red nodes) extend all the way from the ER to the
late secretory compartments, where processing is completed
during granule formation and granules are prepared for regu-
lated release (Figure 1C). The number of proinsulin-interactinging to insulin/proinsulin based on a t test are always gray). Gray lines represent
fied by insulin BIN, black straight lines represent interactions between nodes in
ve previous described function in insulin folding, trafficking, or secretion or an
d proinsulin immunoprecipitate is shown.
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proteins (Figure 1C, group 1 [red]) found in late compartments
agrees with experimental evidence suggesting that proinsulin
to insulin conversion occurs at the acidic clathrin-coated com-
partments derived from trans-Golgi network (Orci et al., 1985).
Green nodes reflect proteins likely to function in late steps of
maturation and release (group 3; log2 values > 2.0). Proteins
with log2 values close to zero or p value greater than 0.5 (based
on a t test corrected for multiple testing) are shaded gray to indi-
cate binding to both insulin and proinsulin based on log values or
due to lack of statistical confidence in preferential binding.
Although network analysis reveals the presence of a small sub-
set of proteins currently recognized to play a role in insulin secre-
tion in normal and/or diabetic conditions (nodes connected by
blue line to insulin) and previously characterized binding partners
for proteins within the insulin BIN (connected by black lines), the
majority of interactions are new. Many of these interactors are
proteins of unknown function in insulin secretory pathway iden-
tified with high spectral counts suggestive of strong interactions
(Figures 1C, 1D, and S1C).
Operation of the Insulin BIN
In order to explore the functional significance of proinsulin/insulin
interaction with proteins recovered in the immunoprecipitates
and to validate our approach, select proteins were chosen based
on previous knowledge of enrichment in islets or secretion. Sub-
networks were created for proteins with known interactions by
choosing a given protein and finding all interactions based on
protein interaction network analysis (PINA) platform (Wu et al.,
2009; Figure S2). Proteins binding only to proinsulin (group 1)
were the smallest group in the insulin BIN. This suggests efficient
folding and export of proinsulin from the ER, an interpretation
that is in agreement with the pulse-chase and electron micro-
scope autoradiography experiments, which show that 90%
of proinsulin is converted to insulin in approximately 1 hr (Huang
and Arvan, 1995; Orci et al., 1986; Wang et al., 2011). In group 2,
we identified a number of proteins likely mediating events lead-
ing to insulin maturation following synthesis, folding, and export
from the ER. Here, for example, we identified COPB2, a subunit
of Golgi coatomer coat complex (COPI) involved in retrograde
Golgi-to-ER transport (Cosson and Letourneur, 1994). As
expected, the COPB2 subnetwork showed interactions with
another component of the complex, COPB1, also found in the
insulin BIN (Figure S2A). Also in group 2, we identified one of
the two prohormone convertases, PCSK2, which has previously
been implicated in the cleavage of proinsulin to insulin (Furuta
et al., 1998). The prohormone convertase PCSK1 was not iden-
tified in our experiment or in previous proteomic analysis
(Suckale and Solimena, 2010), a result potentially reflecting its
low abundance, less stable interaction, and/or poor detection
by mass spectrometry. However, PCSK1 was present in the
subnetwork of PCSK2 through its interaction with islet amyloid
polypeptide (Westermark et al., 2011) found in our data set, sug-
gesting the discovery of interactome pathways relevant to insu-
lin-based b cell biology (Figure S2C). In group 3, we identified
Rab27a, a small cytosolic guanosine triphosphatase (GTPase)
associated with the granule membrane. Rab27a showed prefer-
ential strong association with insulin over proinsulin (Kasai et al.,
2005). A subnetwork consisting of 24 proteins previously924 Cell Reports 4, 921–930, September 12, 2013 ª2013 The Authorreported to interact with Rab27a included five proteins (RIMS1,
RIMS2, Sytl4, Sytl5, and Eef1a1) that were identified in the insulin
BIN (Figure S2D). Apart from validating the known components
of insulin secretory pathway, insulin BIN also revealed proteins
previously uncharacterized in insulin maturation. For example,
we identified Erp44, a member of the thioredoxin-protein disul-
fide-isomerase (PDI) family (Anelli et al., 2002), with a log2 value
of 1.44, indicative of 2.7-fold more binding to proinsulin.
Erp44, localized to ER-Golgi intermediate compartment (ERGIC)
and the cis-Golgi, forms mixed disulfide bonds with ER disulfide
oxidases Ero1a and Ero1b that could potentially mediate the
redox cascade facilitating proinsulin folding. Western blotting
of proinsulin or insulin immunoprecipitates with antibodies
to the above-mentioned proteins largely corroborated their
assigned log2 values, thus validating our insulin BIN data set
(Figure S1C).
In summary, analysis of secretory proteins recovered in the
insulin BIN validates our approach to pathway building and helps
in the visualization of the potential multiprotein machinery (the
insulin BIN) involved in b cell function. Furthermore, it provides
critical insight into a suggested sequential association of previ-
ously known and unknown proteins affecting insulin maturation
in b cell secretory pathway described by Orci and colleagues
(Orci et al., 1986). In the absence of an antibody that binds exclu-
sively to insulin and not to proinsulin, this analysis provides
a guiding tool for differential binding of interactors to pro and
mature forms of insulin along the secretory pathway.
TMEM24, an Insulin BIN Component Enriched
in Pancreatic Islets
Among the top proteins with highest mean normalized spectral
counts in insulin BIN were the bait protein, insulin, microtu-
bule-associated proteins, TMEM24, and IQ motif-containing
GTPase-activating proteins (IQGAPs) (Figure 1D; Table S3).
The role of microtubular system in insulin secretion has been
known for long (Boyd et al., 1982), and more recently, IQGAP1,
enriched in pancreatic b cells, has been shown to act as a regu-
lator of insulin secretion acting through exocyst-septin complex
and cdc42 (Rittmeyer et al., 2008). However, transmembrane
protein 24, TMEM24, is a protein of unknown function, apart
from its presence in few high-throughput studies (Caberoy
et al., 2009; Huttlin et al., 2010; Munton et al., 2007) and a single
in silico analysis that mapped TMEM24 onto human chromo-
some 11q23.3, a region frequently deleted or rearranged in
neuroblastoma (Katoh and Katoh, 2004). To validate insulin
BIN as a platform for discovery of proinsulin/insulin-binding pro-
teins with functional role in insulin maturation and secretion, we
further characterized TMEM24. TMEM24, found throughout
bilaterian animals, consistently showed high level of spectral
counts across all replicates (Table S3; Figure 1D), indicative of
protein abundance, likely reflecting strong interaction. This asso-
ciation with proinsulin and insulin was confirmed by western
blotting of immunoprecipitates with specific antibodies against
TMEM24 (Figure 2A). Coimmunoprecipitation of exogenously
expressed proinsulin-V5 by TMEM24-hemagglutinin (HA) from
MIN6 and COS1 cells further confirmed this interaction (Figures
2B and 2C). Lower expression of proinsulin in COS1 cell extract
compared to MIN6 cell extract could be due to increaseds
Figure 2. TMEM24 Is a Pancreatic-Islet-
Enriched Protein that Interacts and Coloc-
alizes with Insulin
(A) Immunoprecipitates of MIN6 cells were probed
with TMEM24 and insulin antibody; * indicates
proinsulin band and arrowhead insulin band.
(B and C) MIN6 (B) or COS1 (C) cell lysates
expressing TMEM24-HA and proinsulin-V5 were
immunoprecipitated with HA antibodies and
western blotted with anti-HA or V5 antibodies.
(D and E) Cell lysates (20 mg) of different cell lines
(D) or Tissue extracts (10 mg) from a C57BL/6
mouse mouse (E) were western blotted using
antibodies against TMEM24; # indicates that 10 mg
of protein loaded, and the arrow marks the band
corresponding to TMEM24.
(F) Human and mouse islet lysates were probed
with antibodies against TMEM24.
(G) Mouse pancreatic islets were immunoprecipi-
tated with Protein G alone (control) or insulin
antibody; islet lysate, immunoprecipitated pro-
teins, and unbound fractions were probed with
TMEM24 and insulin antibody. IP, immunopre-
cipitation.
(H) MIN6 cells untransfected or transfected with
either pcDNA or FLAG-TMEM24-HA were in vivo
crosslinked with 1 mM DSP. Lysates and FLAG
immunoprecipitates were separated in the pres-
ence or absence of the reducing agent b-mer-
captoethanol followed by western blotting with
antibodies against TMEM24 or HA epitope.
See also Figure S3.constitutive secretion in noninsulinoma cells. TMEM24 shows
high sequence similarity across species and has an N-terminal
region with very weak similarity to synaptotagmin, followed by
a classic C2 domain and a region suggested to bind specifically
to phosphatidylserine (Figure S3; Caberoy et al., 2009), proper-
ties typical of synaptic vesicle regulators. Invertebrate homologs
also have a C-terminal C1 domain (Colo´n-Gonza´lez and Kaza-Cell Reports 4, 921–930, Senietz, 2006), which is largely degenerate
in vertebrates, and lack the zinc-binding
cysteine residues (Figure S3).
To further investigate the tissue-spe-
cific expression of TMEM24, we analyzed
lysates from different cell lines and tis-
sues by western blot. TMEM24 is highly
expressed in kidney and pancreatic tis-
sue as well as in insulinoma cell lines
(Figures 2D and 2E). We also noted a
strong enrichment in brain and neuronal
cells (Figures 2D and 2E), suggesting a
more general role in secretory pathway
function. Islets isolated from mouse and
human pancreas showed strong enrich-
ment of TMEM24 (Figure 2F). In islets,
TMEM24 coprecipitated under physio-
logical conditions with insulin as a larger
protein complex (es), suggesting exis-
tence of dimers and/or oligomers (orother protein complexes). A similar result was observed by
dithiobis succinimidyl propionate (DSP) mediated in vivo cross-
linking experiments with endogenous or exogenously trans-
fected TMEM24 in MIN6 cells (Figures 2G and 2H). Observation
of phosphorylated Ser 374 in our mass spectrometry data com-
bined with a tissue-specific phosphoproteomic study confirmed
phosphorylation of TMEM24 (Huttlin et al., 2010).ptember 12, 2013 ª2013 The Authors 925
Figure 3. Subcellular Localization of TMEM24
(A) Consecutive pancreatic cryosections from mouse perfused with 4%
paraformaldehyde were immunostained using anti-TMEM24 or anti-insulin
followed by Alexafluor-conjugated secondary antibody and DAPI staining.
Images were obtained at 20X magnification.
(B) Insulinoma cell lines MIN6, RINm5F, and INS1-E cells were fixed, per-
meabilized, and stained with anti-TMEM24 or anti-TMEM24 incubated with
antigenic peptide. Stained cells were visualized by confocal microscopy.
(C) INS1-E cells were fixed, permeabilized, and costained with antibodies
against TMEM24 protein (green) and insulin (red). Representative images from
926 Cell Reports 4, 921–930, September 12, 2013 ª2013 The AuthorDifferential extraction of crude membrane fractions from
MIN6 cells showed that TMEM24 is an integral membrane
protein (Figure S4A). To determine the topology of TMEM24 on
the membrane, we transfected mouse fibroblasts with FLAG-
TMEM24-HA, containing an N-terminal Flag epitope tag and a
C-terminal HA epitope tag. Cells were then treated with either
digitonin to selectively permeabilize the plasma membrane or
TX-100 to permeabilize all membranes. As shown in Figure S4B,
the HA epitope was accessible when only the plasma mem-
brane was permeabilized, suggesting its cytosolic localization,
whereas FLAG staining was visible only after internal mem-
branes were permeabilized, confirming that TMEM24 is a type
I transmembrane protein with C-terminal cytosolic region and a
short luminal N terminus. The presence of a large cytosolic
region containing a C2 domain and phosphorylation sites sug-
gests that the functional regulation of the TMEM24 could be
through its C terminus.
Subcellular Localization of TMEM24
To determine the subcellular localization of TMEM24, consecu-
tive mouse pancreatic cryosections were stained with insulin
or TMEM24. As expected, insulin localized specifically to b cells,
whereas TMEM24 showed enrichment in islets compared to
acinar cells but was present in all of the secretory cell types
within the islets (Figure 3A). Insulinoma cell lines were analyzed
by immunofluorescence microscopy to further delineate the
localization of TMEM24within pancreatic b cells. TMEM24 local-
ized to punctate structures, and this staining was lost upon
blocking the antibody with the antigenic peptide (Figure 3B),
confirming specificity of the antibody. TMEM24 did not show
colocalization with several subcellular compartments, including
trans-Golgi network (TGN38), early endosomes (EEA1), mito-
chondria (MitoTracker), or ERGIC (ERGIC 53) (Figure S5A).
Moreover, TMEM24 did not colocalize with plasma membrane-
associated soluble N-ethylmaleimide-sensitive factor attach-
ment protein receptor (SNARE) proteins, syntaxin 1 and
SNAP25, implicated previously in a readily releasable pool of
granules (Figure S5B). However, TMEM24 showed significant
colocalization with insulin-containing punctate structures (Pear-
son’s correlation coefficient of 0.60 ± 0.06; Figure 3C). These
results suggest a possibility that TMEM24 plays a universally
conserved role in regulated secretion, a conclusion consistent
with its abundance in neuronal tissue and colocalization with
insulin in pancreatic b cells.
TMEM24 Is Not Required for Insulin Processing but
Plays a Role in Glucose-Stimulated Insulin Secretion
To determine its potential role in insulin maturation, we tested
whether TMEM24 is required for the processing of proinsulin to
insulin by pulse-chase analysis following lentivirus-mediated
knockdown of TMEM24. MIN6 cells were infected with a
lentivirus containing a small hairpin RNA (shRNA) targeting
TMEM24, and after 4 days of infection, the extent and rate oftwo different experiments are shown. Squared region in middle panels are
enlarged with white arrowheads, indicating punctate structures costained by
both insulin and TMEM24 antibody.
See also Figures S4 and S5.
s
processing proinsulin to insulin were unaffected (Figures 4A–4C),
suggesting that TMEM24 is not required for insulin maturation.
We focused on the role of TMEM24 in insulin secretion using
INS-1-derived 832/13 clonal cells. All of the secretagogues,
including KCl, can evoke rapid release of the RRP responsible
for the first-phase insulin secretion, whereas only glucose and
nutrient metabolites can cause first-phase and a sustained sec-
ond phase secretion by mobilization of the reserve pool (Wang
and Thurmond 2009). Even with 70% reduction in protein levels
of TMEM24 in cells, the basal and KCl-induced insulin secretion
from granules docked to the cell surface remain unchanged,
emphasizing that TMEM24 is unlikely to be a regulator of the
RRP. In contrast, glucose-induced secretion resulting from
recruitment of granules from the cell interior to its periphery
(Ohara-Imaizumi et al., 2007; Wang and Thurmond, 2009) was
consistently reduced by 50% or greater compared to the control
cells (Figure 4D). Similar to INS1-E cells, glucose-stimulated
secretion was reduced upon partial TMEM24 knockdown in
MIN6 pseudoislets (Kelly et al., 2011; Figure 4E) without affecting
the pseudoislet structure. The decrease in TMEM24 did not
cause significant destabilization or reduced expression of
SNARE proteins, considered important for insulin secretion, or
GLUT2 (the b cell glucose transporter), confirming that the
reduced insulin secretion is not due to an overall decrease in
fusion components or decreased uptake of glucose (Figure 4H).
Granule release in the first and second phases of secretion is
tightly coupled to elevated Ca2+ concentration; KCl-mediated
insulin secretion occurs by closure of K+ channels that causes
Ca2+ influx through L-type Ca2+ channels, whereas glucose
stimulation induces various metabolic signals, which in turn
leads to an increase in cytoplasmic Ca2+ concentration (Peder-
sen and Sherman, 2009). To determine whether knockdown of
TMEM24 altered Ca2+ influx, scramble and small hairpin
TMEM24 (shTMEM24)-treated cells were loaded with the Ca2+
binding dye, Fura 2, and stimulated with KCl or glucose. As
shown in Figure 4F, TMEM24 knockdown in cells did not show
any difference in [Ca2+]i concentration when stimulated with
KCl, suggesting that TMEM24 does not affect the activity of
L-type Ca2+ channels responsible for localized Ca2+ influx in
proximity to docked RRP. However, cells lacking TMEM24 did
show a slight increase in intracellular [Ca2+]i upon stimulation
with glucose, possibly due to downstream events reflecting
loss of TMEM24 function (Figure 4G). Together, these results
suggests that impairment of the second phase of insulin secre-
tion in the absence of TMEM24 is not due to reduced Ca2+ levels
but possibly because of Ca2+-mediated, TMEM24-dependent
downstream events leading to the targeting of RP to plasma
membrane for release.
We suggest that TMEM24, a late-acting insulin BIN compo-
nent, is a membrane-associated synaptotagmin-like protein
that associates with proinsulin and insulin. TMEM24 functions
in the sustained glucose induced insulin secretion, possibly by
acting as a missing link in the recruitment of reserve pool of
granules (newcomers) to late events, leading to secretion. The
identification and characterization of TMEM24 suggests that
other components of the insulin BIN are likely to provide, in an
unbiased way, important clues to the largely uncharacterized
molecular features of the insulin processing and granuleCelmaturation pathways required to sustain normal glucose
homeostasis.
DISCUSSION
The work reported herein describes the molecular description of
insulin maturation (the insulin BIN) using a conformational inter-
mediate-based mass spectrometry approach. This approach
allowed us to get at the molecular events, differentiating early
from late steps in the genesis of storage granules, a pathway
that heretofore has been largely limited to morphological
descriptions (Orci et al., 1985, 1986). Our results illustrate that
proinsulin maturation evolves by an unanticipated and surpris-
ingly complex set of protein-protein interactions that reflects
the dynamic folding compartments dictating protein trafficking
through the exocytic pathway (Balch et al., 2008; Hutt and Balch,
2013; Powers and Balch, 2013). The insulin BIN provides a
critical resource to characterize previously unknown molecular
features of the b cell secretory pathway.
Comparison of our interactome data set with whole-cell
human and mouse islet proteomic and gene expression studies
(Mahdi et al., 2012; Marselli et al., 2010; Schrimpe-Rutledge
et al., 2012; Waanders et al., 2009) highlights the physiological
relevance of the interactome to intact islets. Of the 230 proteins
that we identified in the secretory pathway of the MIN6 interac-
tome, 168 were represented in the mouse islet proteome, giving
an overlap of 73% (Waanders et al., 2009). Comparison of
changes in the MIN6 interactome in proteomic abundance with
human islets after 24 hr of 5 mM or 15 mM glucose incubation
(Schrimpe-Rutledge et al., 2012) revealed an overlap of 67.8%
(156 proteins out of 230), where 67% of the proteins in our
interactome were represented to be up (31%), down (27%), or
unchanged (9%) (Table S3), suggesting the interactome compo-
nents are largely very dynamic in response to glucose challenge.
Interestingly, only a limited set of proteins comprising 21 out of
230 (9%) involved in membrane trafficking were found to interact
with proinsulin at early steps of synthesis and folding. This likely
reflects its normally transient residence in the ER during nascent
synthesis followed by efficient folding and export, as shown by
pulse chase and electron microscope autoradiography experi-
ments (Orci et al., 1986; Wang et al., 2011). Early interactors
confirmed previously known functions as well as revealed other
interactions, including the ER oxidase, Erp44. In contrast to
paucity of ER interactors, we discovered a large number of inter-
actors (147 out of 230; 64%) to likely facilitate post-ER, Golgi,
and post-Golgi maturation events directing insulin to secretory
granules and involved in regulated release. Proteins, including
the RabGTPase Rab27a, fell into group 3 and reflect interactions
with mature insulin responsible for secretion (62 out of 230;
27%). The absence of any plasma membrane-associated
SNARE family members in our data set is in agreement with
the idea that only a small pool of granules are docked to the
plasma membrane (7% of total granules [Henquin, 2011]),
with the majority of insulin immunoprecipitated coming from
the reserve pool. Because insulin is the major cargo in a b cell,
our results demonstrate that themultiple direct or indirect protein
interactions (the insulin BIN) shown here may play a major role
in biogenesis and management of the b cell.l Reports 4, 921–930, September 12, 2013 ª2013 The Authors 927
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As a validation of this concept and based on the predictive
value of the insulin BIN, we identified and characterized a type
I transmembrane protein, TMEM24, that is enriched in pancre-
atic islets, strongly associated with proinsulin and insulin with
high spectral coverage, and suggested a functional role in
reserve pool granule maturation for release. Intriguingly,
TMEM24 is an ancient protein, which could reflect a key role in
the evolution of regulated secretory pathway function across
diverse phyla. We demonstrated that TMEM24 knockdown spe-
cifically reduced glucose-induced insulin secretion but not the
readily releasable KCl-induced secretion, providing critical
insight into the molecular components dictating reserve pool
release. Strikingly, all homologs of TMEM24 contain an 130
amino acid C2 domain that folds into an eight-stranded b sand-
wich found in over 100 proteins involved in vesicle trafficking and
signal transduction. C2 domains bind phospholipids in a Ca2+-
dependent manner and mediate protein-membrane associa-
tions that facilitate exocytosis of synaptic vesicles and insulin
granules (Friedrich et al., 2010). Different pools of granules in
b cells have different Ca2+ sensitivities. Thus, availability of
different Ca2+ sensors may be crucial in generating the dynamic
responses critical for glucose homeostasis managed by insulin
release (Pedersen and Sherman, 2009). Although the precise
mechanism by which TMEM24 functions in glucose/Ca2+-sensi-
tive reserve pool granule maturation remains to be determined,
one speculative possibility is that TMEM24 could undergo
glucose-induced phosphorylation/dephosphorylation changes.
These changes could mediate its interaction with other proteins
to facilitate the recruitment of newcomer granules to phospho-
lipid bilayers in a Ca2+-dependent fashion, a model consistent
with the similarity of TMEM24 to synaptotagmin family members
and their role(s) in synchronous vesicle release (Figure 4I).
Our quantitative description of themolecular pathway defining
the b cell secretory axis opens the door for an unprecedented
level of insight into the complex environment controlling b cell
secretory axis function. The insulin BIN sets the stage for discov-
ery and mechanistic analyses of proteins in pancreatic b cells,
likely contributing to glucose homeostasis in health and disease.
EXPERIMENTAL PROCEDURES
Antibodies, Plasmids, and Cell Lines
Detailed description of all antibodies, DNA constructs, cell lines, and shRNA
lentiviral purification and concentration is described in the Extended Experi-
mental Procedures.Figure 4. TMEM24 Has a Role in Glucose-Stimulated Insulin Secretion
(A) MIN6 cells transduced with scrambled or shTMEM24 were pulse labeled w
cipitated with antibodies against insulin and samples were analyzed by autoradi
(B) Ratios of proinsulin to insulin at different time points were quantified from the
(C) Amounts of TMEM24 in lysates were quantified, normalized to actin, and plo
(D and E) INS1-E cells (D) or MIN6 pseudoislets (E) were transduced with scramble
or 35 mM KCl were assayed by ELISA. Relative insulin secretion was calculated
three independent knockdown and secretion assays shown (*p < 0.05).
(F and G) MIN6 cells transduced with scrambled or shTMEM24 loaded with Fura 2
25 mM glucose. Data represented as average ± SEM from indicated number of
(H) Levels of SNARE proteins and GLUT2 were assessed by western blotting up
(I) Model for proposed function of TMEM24 indicates possible role for TMEM
Figure illustrates a Ca2+-dependent and perhaps phosphorylation-dependent
glucose.
CelImmunoprecipitation of Insulin
MIN6 cell pellets were resuspended in 50 mM Tris pH 7.5, 150 mM NaCl, and
1% TX-100 with protease inhibitor cocktail (Roche); lysed on ice for 30 min;
clarified by centrifugation; and precleared with Protein G beads (Amersham)
for 1 hr at 4C. Supernatant was incubated either with Protein G beads alone
(control) or with control immunoglobulin G (IgG), insulin, or proinsulin anti-
bodies crosslinked to beads for 3 to 4 hr at 4C. The beads were pelleted
and washed with lysis buffer twice and with buffer without detergent once.
Bound proteins were eluted with 100 ml of 50 mM Tris pH 7.5 and 1% SDS
at 100C for 5 min. Eluted samples (1/10th total) were analyzed by silver stain
before analysis bymass spectrometry. Rest of the eluate was precipitated with
four volumes of acetone at20C for overnight, spun at maximum speed, and
pellets were dried and stored at 80C.
Pulse-Chase Analysis
MIN6 cells were plated at 83 105 cells in 35 mm dishes and infected with 20 ml
of concentrated scrambled or TMEM24 shRNA virus. After 72 hr of infection,
cells were washed with PBS twice, and pulse-chase analysis was carried
out as described in the Extended Experimental Procedures.
ELISA
ELISA was performed using Rat/mouse ELISA kit (Millipore, EZRMI-13K)
according to the manufacturer’s instructions and as described in detail in
the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2013.07.050.
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ography.
pulse chase analysis by setting the zero time point to 100.
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